Lior Zangi

Company: Icahn School of Medicine at Mount Sinai

Job title: Associate Professor of Cardiology; Genetics & Genomic Sciences

Bio:

Seminar: Therapeutic Potential of Cardiomyocytes Specific Modified mRNA Translational System 2.0 (SMRTs 2.0) with Minimally Invasive Delivery to the Heart

• Modified mRNA is an important and safe tool to control protein expression in the heart
• Cardiomyocytes specific modified mRNA translational system can be used to induce cardiomyocytes proliferation and cardiac regeneration post myocardial infarction
• Cardiomyocytes specific modified mRNA translationa system 2.0 can be used with minimally invasive delivery to induce cardiac protection against ischemia or cardiac toxicity injury

Day: Day Two